Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INDUCED AKATHISIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 161 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Haut, F; Clos, S
      Acute akathisia and sodium valproate

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    2. Hirose, S
      Restlessness in suboccipital muscles as a manifestation of akathisia

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    3. Atbasoglu, EC; Schultz, SK; Andreasen, NC
      The relationship of akathisia with suicidality and depersonalization amongpatients with schizophrenia

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    4. Hansen, L
      A critical review of akathisia, and its possible association with suicidalbehaviour

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    5. Vinson, DR; Migala, AF; Quesenberry, CP
      Slow infusion for the prevention of akathisia induced by prochlorperazine:A randomized controlled trial

      JOURNAL OF EMERGENCY MEDICINE
    6. Vinson, DR
      Frequency of adverse reactions to prochlorperazine in the ED: A response

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    7. Rascol, O; Fabre, N
      Dyskinesia: L-dopa-induced and tardive dyskinesia

      CLINICAL NEUROPHARMACOLOGY
    8. Fischel, T; Hermesh, H; Aizenberg, D; Zemishlany, Z; Munitz, H; Benjamini, Y; Weizman, A
      Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    9. Collins, RW; Jones, JB; Walthall, JDH; Chisholm, CD; Giles, BK; Brizendine, EJ; Cordell, WH
      Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: A prospective,randomized, controlled trial

      ANNALS OF EMERGENCY MEDICINE
    10. Vinson, DR; Drotts, DL
      Diphenhydramine for the prevention of akathisia induced by prochlorperazine: A randomized, controlled trial

      ANNALS OF EMERGENCY MEDICINE
    11. Chelben, J; Strous, RD; Lustig, M; Baruch, Y
      Remission of SSRI-induced akathisia after switch to nefazodone

      JOURNAL OF CLINICAL PSYCHIATRY
    12. Nelson, DE
      Akathisia - A brief review

      SCOTTISH MEDICAL JOURNAL
    13. Brasic, JR
      Clinical assessment of tics

      PSYCHOLOGICAL REPORTS
    14. Wood, MD; Reavill, C; Trail, B; Wilson, A; Stean, T; Kennett, GA; Lightowler, S; Blackburn, TP; Thomas, D; Gager, TL; Riley, G; Holland, V; Bromidge, SM; Forbes, IT; Middlemiss, DN
      SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

      NEUROPHARMACOLOGY
    15. Kulkarni, SK; Naidu, PS
      Tardive dyskinesia: An update

      DRUGS OF TODAY
    16. Stubbs, JH; Hutchins, DA; Mountjoy, CQ
      Relationship of akathisia to aggressive and self-injurious behaviour: A prevalence study in a UK tertiary referral centre

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    17. Healy, D
      Emergence of antidepressant induced suicidality

      PRIMARY CARE PSYCHIATRY
    18. Jimenez-Jimenez, FJ; Molina, JA
      Extrapyramidal symptoms associated with selective serotonin reuptake inhibitors - Epidemiology, mechanisms and management

      CNS DRUGS
    19. Caligiuri, MP; Jeste, DV; Lacro, JP
      Antipsychotic-induced movement disorders in the elderly - Epidemiology andtreatment recommendations

      DRUGS & AGING
    20. Havaki-Kontaxaki, BJ; Kontaxakis, VP; Christodoulou, GN
      Prevalence and characteristics of patients with pseudoakathisia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    21. Poyurovsky, M; Nave, R; Epstein, R; Tzischinsky, O; Schneidman, M; Barnes, TRE; Weizman, A; Lavie, P
      Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    22. Modestin, J; Stephan, PL; Erni, T; Umari, T
      Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia

      SCHIZOPHRENIA RESEARCH
    23. Staedt, J; Dewes, D; Danos, P; Stoppe, G
      Can chronic neuroleptic treatment promote sleep disturbances in elderly schizophrenic patients?

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    24. Boffa, E; Lofchy, J
      Paroxetine and tardive akathisia (vol 45, pg 196, 2000)

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    25. Boffa, E; Lofchy, J
      Paroxetine and tardive akathisia

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    26. Duncan, EJ; Adler, LA; Stephanides, M; Sanfilipo, M; Angrist, B
      Akathisia and exacerbation of psychopathology: A preliminary report

      CLINICAL NEUROPHARMACOLOGY
    27. Berardi, D; Giannelli, A; Barnes, TRE
      Clinical correlates of akathisia in acute psychiatric inpatients

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    28. Vinson, DR; Drotts, DL
      Akathisia and prochlorperazine - In reply

      ANNALS OF EMERGENCY MEDICINE
    29. Tuisku, K; Lauerma, H; Holi, MM; Honkonen, T; Rimon, R
      Akathisia masked by hypokinesia

      PHARMACOPSYCHIATRY
    30. Dose, M
      Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes

      PHARMACOPSYCHIATRY
    31. Marsalek, M
      Tardive drug-induced extrapyramidal syndromes

      PHARMACOPSYCHIATRY
    32. Hofmann, M; Seifritz, E; Botschev, C; Krauchi, K; Muller-Spahn, F
      Serum iron and ferritin in acute neuroleptic akathisia

      PSYCHIATRY RESEARCH
    33. Luthra, V; Pinninti, NR; Yoder, K; Musthaq, MS; Umapathy, C; Levinson, DF
      Is akathisia associated with poor clinical response to antipsychotics during acute hospital treatment?

      GENERAL HOSPITAL PSYCHIATRY
    34. Hirose, S
      Restlessness of respiration as a manifestation of akathisia: Five case reports of respiratory akathisia

      JOURNAL OF CLINICAL PSYCHIATRY
    35. Sachdev, PS; Brune, M
      Animal models of acute drug-induced akathisia - a review

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    36. Eichhammer, P; Albus, M; Borrmann-Hassenbach, M; Schoeler, A; Putzhammer, A; Frick, U; Klein, HE; Rohrmeier, T
      Association of dopamine D3-receptor gene variants with neuroleptic inducedakathisia in schizophrenic patients: A generalization of Steen's study on DRD3 and tardive dyskinesia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    37. Miller, CH; Fleischhacker, WW
      Managing antipsychotic-induced acute and chronic akathisia

      DRUG SAFETY
    38. Hirose, S; Ashby, CR
      Intravenous biperiden in akathisia: An open pilot study

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
    39. Gruber, O; Northoff, G; Pflug, B
      Effects of activation procedures in acute neuroleptic-induced akathisia

      NERVENARZT
    40. Stubbs, JH; Halstead, SM
      Peudoakathisia: A review and two case reports

      COMPREHENSIVE PSYCHIATRY
    41. Robertson, MM
      Tourette syndrome, associated conditions and the complexities of treatment

      BRAIN
    42. Leung, A; Chue, P
      Sex differences in schizophrenia, a review of the literature

      ACTA PSYCHIATRICA SCANDINAVICA
    43. Young, JL; Spitz, RT; Hillbrand, M; Daneri, G
      Medication adherence failure in schizophrenia: A forensic review of rates,reasons, treatments, and prospects

      JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW
    44. Ruedrich, S; Erhardt, L
      Beta-adrenergic blockers in mental retardation and developmental disabilities

      MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
    45. Tuisku, K; Lauerma, H; Holi, M; Markkula, J; Rimon, R
      Measuring neuroleptic-induced akathisia by three-channel actometry

      SCHIZOPHRENIA RESEARCH
    46. Ghavanini, AA
      Acute extrapyramidal symptoms following abrupt discontinuation of propranolol

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    47. Poyurovsky, M; Weizman, A
      Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    48. Drotts, DL; Vinson, DR
      Prochlorperazine induces akathisia in emergency patients

      ANNALS OF EMERGENCY MEDICINE
    49. Day, RK
      Psychomotor agitation: poorly defined and badly measured

      JOURNAL OF AFFECTIVE DISORDERS
    50. Brune, M
      The incidence of akathisia in bipolar affective disorder treated with neuroleptics - a preliminary report

      JOURNAL OF AFFECTIVE DISORDERS
    51. Vandel, P; Haffen, E; Vandel, S; Bonin, B; Nezelof, S; Sechter, D; Broly, F; Bizouard, P; Dalery, J
      Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    52. Nair, CJ; Josiassen, RC; Abraham, G; Stanilla, JK; Tracy, JI; Simpson, GM
      Does akathisia influence psychopathology in psychotic patients treated with clozapine?

      BIOLOGICAL PSYCHIATRY
    53. MORISHITA S; AOKI S; WATANABE S
      CLONAZEPAM AS A THERAPEUTIC ADJUNCT TO IMPROVE THE MANAGEMENT OF PSYCHIATRIC-DISORDERS

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    54. GOLDBERG RJ
      SELECTIVE SEROTONIN REUPTAKE INHIBITORS - INFREQUENT MEDICAL ADVERSE-EFFECTS

      Archives of family medicine
    55. GERBER PE; LYND LD
      SELECTIVE SEROTONIN-REUPTAKE INHIBITOR-INDUCED MOVEMENT-DISORDERS

      The Annals of pharmacotherapy
    56. BONNETBRILHAULT F; THIBAUT F; LEPRIEUR A; PETIT M
      A CASE OF PAROXETINE-INDUCED AKATHISIA AND A REVIEW OF SSRI-INDUCED AKATHISIA

      European psychiatry
    57. DIEDERICH NJ; GOETZ CG
      DRUG-INDUCED MOVEMENT-DISORDERS

      Neurologic clinics
    58. Brune, M; Braunig, P; Schiefenhovel, W
      Ethological remarks on diagnosis and therapy of neuroleptic-induced akathisia

      NERVENHEILKUNDE
    59. Gruber, O; Northoff, G; Pflug, B
      Subjective experience of patients with acute neuroleptic-induced akathisia

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    60. CORTESE L; POURCHERBOUCHARD E; WILLIAMS R
      ASSESSMENT AND MANAGEMENT OF ANTIPSYCHOTIC-INDUCED ADVERSE EVENTS

      Canadian journal of psychiatry
    61. DIMASCIO M; DIGIOVANNI G; DIMATTEO V; PRISCO S; ESPOSITO E
      SELECTIVE SEROTONIN REUPTAKE INHIBITORS REDUCE THE SPONTANEOUS ACTIVITY OF DOPAMINERGIC-NEURONS IN THE VENTRAL TEGMENTAL AREA

      Brain research bulletin
    62. POYUROVSKY M; WEIZMAN A
      SEROTONIN ANTAGONISTS AND NEUROLEPTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS

      Israel journal of psychiatry and related sciences
    63. LEVINSON AJ; GARSIDE S; ROSEBUSH PI; MAZUREK MF
      HALOPERIDOL INDUCES PERSISTENT DOWN-REGULATION OF TYROSINE-HYDROXYLASE IMMUNOREACTIVITY IN SUBSTANTIA-NIGRA BUT NOT VENTRAL TEGMENTAL AREA IN THE RAT

      Neuroscience
    64. LAMBERT MT; TRUTIA C; PETTY F
      EXTRAPYRAMIDAL ADVERSE-EFFECTS ASSOCIATED WITH SERTRALINE

      Progress in neuro-psychopharmacology & biological psychiatry
    65. LANE RM
      SSRI-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS AND AKATHISIA - IMPLICATIONSFOR TREATMENT

      JOURNAL OF PSYCHOPHARMACOLOGY
    66. MILLER CH; MOHR F; UMBRICHT D; WOERNER M; FLEISCHHACKER WW; LIEBERMAN JA
      THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE, AND CONVENTIONAL ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    67. Brasic, JR; Barnett, JY; Sheitman, BB; Lafargue, RT; Ahn, SC
      Clinical assessment of adventitious movements

      PSYCHOLOGICAL REPORTS
    68. MAZUREK MF; SAVEDIA SM; BOBBA RS; GARSIDE S; ROSEBUSH PI
      PERSISTENT LOSS OF TYROSINE-HYDROXYLASE IMMUNOREACTIVITY IN THE SUBSTANTIA-NIGRA AFTER NEUROLEPTIC WITHDRAWAL

      Journal of Neurology, Neurosurgery and Psychiatry
    69. OHASHI K; HAMAMURA T; LEE Y; FUJIWARA Y; KURODA S
      PROPRANOLOL ATTENUATES HALOPERIDOL-INDUCED FOS EXPRESSION IN DISCRETEREGIONS OF RAT-BRAIN - POSSIBLE BRAIN-REGIONS RESPONSIBLE FOR AKATHISIA

      Brain research
    70. LAGORIO J; THOMPSON VA; STERNBERG D; DORJE P
      AKATHISIA AND ANESTHESIA - REFUSAL OF SURGERY AFTER THE ADMINISTRATION OF METOCLOPRAMIDE

      Anesthesia and analgesia
    71. STEFANSKI R; GOLDBERG SR
      SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS - POTENTIAL IN THE TREATMENT OF PSYCHIATRIC-DISORDERS

      CNS DRUGS
    72. HOLLOMAN LC; MARDER SR
      MANAGEMENT OF ACUTE EXTRAPYRAMIDAL EFFECTS INDUCED BY ANTIPSYCHOTIC-DRUGS

      American journal of health-system pharmacy
    73. CALEY CF
      EXTRAPYRAMIDAL REACTIONS AND THE SELECTIVE SEROTONIN-REUPTAKE INHIBITORS

      The Annals of pharmacotherapy
    74. VANDEL P; BONIN B; LEVEQUE E; SECHTER D; BIZOUARD P
      TRICYCLIC ANTIDEPRESSANT-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS

      European neuropsychopharmacology
    75. MILLER CH; HUMMER M; OBERBAUER H; KURZTHALER I; DECOL C; FLEISCHHACKER WW
      RISK-FACTORS FOR THE DEVELOPMENT OF NEUROLEPTIC-INDUCED AKATHISIA

      European neuropsychopharmacology
    76. BODFISH JW; NEWELL KM; SPRAGUE RL; HARPER VN; LEWIS MH
      AKATHISIA IN ADULTS WITH MENTAL-RETARDATION - DEVELOPMENT OF THE AKATHISIA RATINGS OF MOVEMENT SCALE (ARMS)

      American journal of mental retardation
    77. POYUROVSKY M; SCHNEIDMAN M; WEIZMAN A
      SUCCESSFUL TREATMENT OF FLUOXETINE-INDUCED DYSTONIA WITH LOW-DOSE MIANSERIN

      Movement disorders
    78. BRUNE M; BRAUNIG P
      AKATHISIA

      Fortschritte der Neurologie, Psychiatrie
    79. DECH H; NORTHOFF G
      SYMPTOMATOLOGY OF AKATHISIA

      Fortschritte der Neurologie, Psychiatrie
    80. HANSEN TE; CASEY DE; HOFFMAN WF
      NEUROLEPTIC INTOLERANCE

      Schizophrenia bulletin
    81. MIYAWAKI E; MEAH Y; KOLLER WC
      SEROTONIN, DOPAMINE, AND MOTOR EFFECTS IN PARKINSONS-DISEASE

      Clinical neuropharmacology
    82. COHEN LJ
      RATIONAL DRUG-USE IN THE TREATMENT OF DEPRESSION

      Pharmacotherapy
    83. GILL HS; DEVANE CL; RISCH SC
      EXTRAPYRAMIDAL SYMPTOMS ASSOCIATED WITH CYCLIC ANTIDEPRESSANT TREATMENT - A REVIEW OF THE LITERATURE AND CONSOLIDATING HYPOTHESES

      Journal of clinical psychopharmacology
    84. LEWIS CF; DEQUARDO JR; TANDON R
      DYSTONIA ASSOCIATED WITH TRAZODONE AND SERTRALINE

      Journal of clinical psychopharmacology
    85. TU JB
      PSYCHOPHARMACOGENETIC BASIS OF MEDICATION-INDUCED MOVEMENT-DISORDERS

      International clinical psychopharmacology
    86. MARKKULA J; LAUERMA H
      MIANSERIN AND RESTLESS LEGS

      International clinical psychopharmacology
    87. BONIN B; VANDEL P; SECHTER D; BIZOUARD P
      PAROXETINE AND GALACTORRHEA

      Pharmacopsychiatry
    88. SPIVAK B; MESTER R; ABESGAUS J; WITTENBERG N; ADLERSBERG S; GONEN N; WEIZMAN A
      CLOZAPINE TREATMENT FOR NEUROLEPTIC-INDUCED TARDIVE-DYSKINESIA, PARKINSONISM, AND CHRONIC AKATHISIA IN SCHIZOPHRENIC-PATIENTS

      The Journal of clinical psychiatry
    89. JIMENEZJIMENEZ FJ; GARCIARUIZ PJ; MOLINA JA
      DRUG-INDUCED MOVEMENT-DISORDERS

      Drug safety
    90. BRASIC JR; BARNETT JY; AISEMBERG P; AHN SC; NADRICH RH; KAPLAN D; AHMAD R; MENDONCA MD
      DYSKINESIAS SUBSIDE OFF ALL MEDICATION IN A BOY WITH AUTISTIC DISORDER AND SEVERE MENTAL-RETARDATION

      Psychological reports
    91. BRASIC JR; BARNETT JY
      HYPERKINESIAS IN A PREPUBERTAL BOY WITH AUTISTIC DISORDER TREATED WITH HALOPERIDOL AND VALPROIC ACID

      Psychological reports
    92. BAKHEIT AMO
      THE SYNDROME OF MOTOR RESTLESSNESS - A TREATABLE BUT UNDER-RECOGNIZEDDISORDER

      Postgraduate medical journal
    93. KUDO S; UMEHARA K; ABE Y; FURUKAWA M; ODOMI M
      INTRACEREBRAL PENETRATION OF CARTEOLOL HYDROCHLORIDE IN RATS

      Psychopharmacology
    94. ARYA DK
      IS THE 5-HYDROXYTRYPTAMINE (5-HT) NEUROTRANSMITTER SYSTEM INVOLVED INREGULATION OF EXTRAPYRAMIDAL SYMPTOMS

      Journal of drug development and clinical practice
    95. EBERHARD G
      THE EXTRAPYRAMIDAL SYMPTOMS RATING-SCALE (ESRS) AND ITS USE IN THE EVALUATION OF RISPERIDONE

      Journal of drug development and clinical practice
    96. BARNES TRE; MCPHILLIPS MA
      ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS - ROLE OF ANTICHOLINERGIC DRUGS IN TREATMENT

      CNS DRUGS
    97. AHMED I; TAKESHITA J
      CLONIDINE - A CRITICAL-REVIEW OF ITS ROLE IN THE TREATMENT OF PSYCHIATRIC-DISORDERS

      CNS DRUGS
    98. BAILLY D
      THE ROLE OF BETA-ADRENOCEPTOR BLOCKERS IN THE TREATMENT OF PSYCHIATRIC-DISORDERS

      CNS DRUGS
    99. CASEY DE
      EXTRAPYRAMIDAL SYNDROMES - EPIDEMIOLOGY, PATHOPHYSIOLOGY AND THE DIAGNOSTIC DILEMMA

      CNS DRUGS
    100. HUMMER M; FLEISCHHACKER WW
      COMPLIANCE AND OUTCOME IN PATIENTS TREATED WITH ANTIPSYCHOTICS - THE IMPACT OF EXTRAPYRAMIDAL SYNDROMES

      CNS DRUGS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 12:54:15